Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2019-01-31 Director's Dealing
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Final Director's Interest Notice 2 pages 241.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options, and the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director. The document length is short and focused solely on director interests, with no financial statements or broader company information. Therefore, it fits the definition of a Director's Dealing report.
2019-01-31 English
Appendix 4C - quarterly 5 pages 211.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B' and contains detailed financial data including consolidated statements of cash flows for the current quarter and year to date. It includes sections on cash flows from operating, investing, and financing activities, reconciliation of cash and cash equivalents, payments to directors, financing facilities, estimated cash outflows for the next quarter, and acquisitions and disposals of business entities. The document is 8,342 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. The presence of detailed financial statements and the quarterly period covered aligns with the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or certification but a full quarterly financial report. Therefore, the correct classification is IR (Interim / Quarterly Report). Q4 2018
2019-01-30 English
Quarter 4 Update 3 pages 338.8KB
Interim / Quarterly Report Classification · 90% confidence The document is an ASX announcement dated 31st Jan 2019 providing a quarterly update on business development progress and financial highlights for the December 2018 quarter. It includes operational updates, cash receipts, expenditure, investment in R&D, and business development activities. The mention of 'Appendix 4C for the December 2018 quarter' indicates it is a quarterly cash flow report typical for Australian listed companies. The content is focused on quarterly operational and financial data rather than a full annual report or earnings release. The document length is about 4854 characters, which is consistent with a quarterly update announcement rather than a full interim report. Therefore, the document fits best as an Interim / Quarterly Report (IR). Q4 2018
2019-01-30 English
Presentation for Cantech19 in Toronto on 29-30 January 2019 16 pages 4.2MB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 25th January 2019, presenting a detailed investor presentation for the Cantech19 conference in Toronto. It includes company background, product descriptions, market intelligence, business models, and strategic initiatives. The content is structured as a presentation with slides and detailed information about the company's products, market, and management team. There are no financial statements or quarterly results, nor is it a regulatory filing or a brief announcement. The document is clearly a detailed presentation aimed at investors and stakeholders, consistent with the definition of an Investor Presentation (IP).
2019-01-24 English
Change of Director's Interest Notice 3 pages 97.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities and contracts, including specifics about securities held, acquisitions, disposals, and contracts related to the director. The document is a formal notification of a director's personal share transactions or interests. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3670 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. Therefore, the correct classification is DIRS with high confidence.
2019-01-17 English
Change of Director's Interest Notice 3 pages 98.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities and contracts, including specifics about securities held, options to be issued, and related dates. The content is focused on reporting personal share transactions or interests of a company director. The document length is 3672 characters, which is consistent with a detailed notice rather than a brief announcement. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2019-01-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.